SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (632)6/15/1998 12:35:00 AM
From: BigDaddyMac  Read Replies (2) | Respond to of 5402
 
Mr. Prospector, that is great that nobody has the gotten the runs or fever yet from this stuff, but wait for 2 more years and if people start dying there will be problems.

The trials on this will take forever

call the FDA yourself, i'm just reporting what i was told by them

mitchell



To: Prospector who wrote (632)6/15/1998 1:51:00 AM
From: sdheart  Respond to of 5402
 
PHER-02 is a second generation drug, pointed out many times in the past.
The first generation has already been approved by the FDA, and
tested on 15,000 humans with no side effects.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News